Google DeepMind has launched the groundbreaking AI model, AlphaGenome, tailored for the intricate task of DNA sequence analysis and predicting the effects of mutations. This state-of-the-art model can handle sequences spanning up to one million base pairs, delivering predictions with pinpoint accuracy at the single base pair level. Furthermore, AlphaGenome boasts the capability to directly forecast RNA splicing sites and expression levels directly from DNA sequences. By providing comprehensive predictions of molecular properties, such as gene expression and RNA splicing, AlphaGenome holds immense potential for the exploration of rare genetic diseases. Currently, the model is openly accessible via an API for non-commercial research purposes, heralding a significant step forward in the advancement of genetic disease research and personalized medicine.